Novozymes Biopharma secures business innovation award

26-Jul-2011 - United Kingdom

Novozymes Biopharma, part of Novozymes A/S, received the 2011 Nottingham Evening Post (NEP) Business Award in the business innovation category, for its recombinant human albumin range. The company has been recognized for its outstanding contribution to pushing back scientific frontiers by developing innovative, process improving solutions for the medical device and pharmaceutical manufacturing industries. The NEP business awards are designed to reward organizations in the region for setting new benchmarks in their industries and the company is delighted to add this accolade to its growing collection of awards.

“Novozymes Biopharma is pleased to have been selected for the business innovation award”, comments Sally Vernon, Customer Communications Manager, Novozymes Biopharma. “We have a great infrastructure in the business and a dedication to science which is what makes us important to our customers. We are committed to working with customers to improve their products and processes and with the large pharmaceutical companies looking to reformulate many of their patents, we can support them by giving them the edge over their competitors.”

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances